the pros and cons of genomic markers for biopsy guidance
Published 5 years ago • 97 plays • Length 12:30Download video MP4
Download video MP3
Similar videos
-
14:50
the "who's" of genomic markers: who to re biopsy
-
14:03
the pros and cons of imaging for biopsy guidance
-
33:52
the use of genomic markers and prostate biopsy decisions
-
17:33
the "who's" of genomic markers: who to biopsy
-
12:53
the "who's" of genomic markers: who to treat
-
12:05
genomic markers and dna sequencing testing
-
13:24
genetics and genomic biomarkers: how molecular markers and mpmri play a role
-
8:53
pro: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
26:20
mapping pathology as a guide to focal therapy the role of mapping biopsies and tissue markers
-
10:13
the role of genetic testing in prostate cancer
-
2:38
the future of genomic markers and dna sequencing in prostate cancer youtube
-
21:53
can one biopsy event determine type and amount of focal therapy treatment?
-
20:50
active surveillance 2021 - from bench to bedside
-
11:39
urologic debate part 2: mri vs. molecular markers: which one should i use? markers perspective
-
21:50
mr guided biopsy
-
14:24
urologic debate part 1: mri vs. molecular markers: which one should i use? mri perspective
-
26:42
transperineal mapping biopsy defines tumor type and location
-
21:30
next generation biomarkers: as reflex, combination, or first line?
-
11:03
biomarkers for prostate cancer: whom to treat